Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 36186

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : May | Volume : 18 | Issue : 5 | Page : FF01 - FF06 Full Version

Evaluation of Preclinical Toxicity of Methanolic Extract of Sargassum tenerrimum using the Zebrafish Model


Published: May 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/66816.19397
Raman Yadav, Punnagai Kumaravelu, Subburaya Umamaheswari, Viswanathan Subramanian, Suvarna Jyoti Kantipudi

1. PhD Scholar, Department of Pharmacology, Sri Ramachandra Institution of Higher Education and Research, Chennai, Tamil Nadu, India. 2. Professor and Head, Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu, India. 3. Professor, Department of Pharmacology, Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India. 4. Professor, Department of Pharmacology, Meenakshi Academy of Higher Education and Research, Chennai, Tamil Nadu, India. 5. Associate Professor, Department of Pharmacology, Sri Ramachandra Institution of Higher Education and Research, Chennai, Tamil Nadu, India.

Correspondence Address :
Dr. Punnagai Kumaravelu,
Professor and Head, Department of Pharmacology, Tagore Medical College and Hospital, Chennai-600127, Tamil Nadu, India.
E-mail: kpunnagaimd@gmail.com

Abstract

Introduction: In the field of biomedicine, marine algae have gained significant attention due to the abundance of bioactive compounds they contain. However, studies on the chronic toxicity of algae are limited.

Aim: To evaluate the in-vitro, in-vivo acute, and subchronic toxicity of Sargassum tenerrimum (S. tenerrimum) in an adult zebrafish model.

Materials and Methods: The current preclinical toxicological interventional study was conducted at the Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, Tamil Nadu, India, in September 2022. The algae S. tenerrimum was extracted with methanol using Soxhlet extraction. In-vitro toxicity of S. tenerrimum was performed using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay on the SH-SY5Y cell line. Acute toxicity was carried out for 96 hours according to Organisation for Economic Cooperation and Development (OECD) 203 guidelines, and subchronic toxicity was carried out for 14 days on the zebrafish model using the immersion method. Additionally, histopathological changes were observed after the acute toxicity study, and the Lethal Concentration 50 (LC50) value was analysed.

Results: The MTT assay of the methanolic extract of S. tenerrimum revealed an LC50 value of 140.014 μg/mL. An acute toxicity study conducted on zebrafish for 96 hours showed an LC50 value of 504.669 mg/L. Subchronic toxicity was done for 14 days, and on the 14th day of exposure, the LC50 value was found to be 404.196 mg/L. Histopathological changes were observed at higher concentrations (800 mg/L) of algal extract.

Conclusion: The present study revealed that the methanolic extract of S. tenerrimum showed a toxic effect at higher concentrations on the zebrafish model. However, at lower concentrations, S. tenerrimum was deemed safe for further exploration of pharmacological activities in a zebrafish model.

Keywords

Cytotoxicity, Lethal concentration 50 values, Macroalgae, Methanol, Soxhlet

Macroalgae hold a significant importance in pharmaceutical research due to their rich repertoire of bioactive compounds and their potential therapeutic applications. Particularly, brown algae offer a vast array of natural compounds, including polysaccharides, proteins, polyphenols, pigments, fatty acids, and secondary metabolites which possess diverse biological activities (1). Pharmaceutical researchers are chiefly interested in these compounds as they exhibit antioxidant, anti-inflammatory, antiviral, antibacterial, neurodegenerative diseases, and anticancer properties (2),(3). Algae provide a valuable source for drug discovery and development, serving as a starting point for identifying novel compounds with therapeutic potential. The importance of algae in pharmaceutical research lies in their vast potential for discovering new drugs, developing therapies, and addressing various medical challenges (4).

Sargassum tenerrimum, a brown alga, holds significant importance in pharmaceutical research and shows promising potential for future applications. It is commonly found on the coasts of various Asian nations like India, China, and Pakistan. In India, it is found along the shores of the states of Maharashtra (Bombay), Tamil Nadu (Tuticorin, Tirunelveli Cape Comorin, and Krusada Travancore), and Gujarat (Okha, Adatrareef, Cannanore, Dwarka, Saurashtra, Jalleshwar, Varaval, Gulf of Kutch) (5). S. tenerrimum, a remarkable brown alga, has been the subject of a few scientific investigations that have shed light on its rich biochemical composition. These studies (6),(7) have revealed a diverse array of secondary metabolites within this plant, underscoring its significance in the field of pharmacology and natural product research. Among the various secondary metabolites identified in S. tenerrimum (8), flavonoids stand out as a prominent group. Flavonoids are well known for their antioxidant properties and potential health benefits (9). Alkaloids, another class of compounds found in this plant, often possess pharmacological activities, making them valuable for drug discovery and development. Alkaloids, saponins, carbohydrates, and anthraquinone glycosides are also notable constituents of S. tenerrimum. Saponins have been associated with various biological activities, including anti-inflammatory and anticancer properties (10),(11). In addition to these compounds, steroids, phenolic compounds, and tannins have been identified in S. tenerrimum. Steroids, such as phytosterols, can have cholesterol-lowering effects and are important in the synthesis of hormones (12). Phenolic compounds have antioxidant and anti-inflammatory properties and are linked to potential health benefits (13). Tannins, known for their astringent properties, have been used in traditional medicine for their ability to bind and precipitate proteins, making them relevant in various therapeutic applications (14). In addition to their chemical diversity, these secondary metabolites have been investigated for their pharmacological properties, shedding light on the plant’s potential medicinal applications.

Notably, S. tenerrimum has been studied for its antimicrobial properties, demonstrating efficacy against viruses and bacteria (15). This suggests its potential use in the development of antiviral and antibacterial agents. Furthermore, the plant has exhibited anti-inflammatory and antiplasmodial activities (16). Anti-inflammatory properties suggest its potential in alleviating inflammation-related disorders, while antiplasmodial activity highlights its relevance in combating malaria, which is caused by Plasmodium parasites. Moreover, S. tenerrimum has shown antioxidant properties, which are crucial for combating oxidative stress and preventing various diseases associated with free radical damage. Additionally, its antitumor activity indicates a possible role in cancer therapy (17), while its antiallergic effects suggest potential use in managing allergic conditions (18). The anticoagulant property of this algae is significant in the context of preventing excessive blood clotting, a condition associated with various cardiovascular diseases (19). Its antidiabetic activity suggests a potential role in managing diabetes mellitus, a widespread metabolic disorder (20).

The scientific discipline of toxicology seeks to understand how certain substances may be hazardous to living things. The right dose differentiates between poison and treatment. The process of toxicological screening plays a crucial role in the advancement of new medications and the exploration of the therapeutic capabilities of compounds and crude extracts (21). This provides a comprehensive explanation of the consequences of poison, including symptoms, biomechanism, treatment, and detection. In addition, the use of animal models is essential to comprehend the appropriate dose and concentration of fresh crude extract or by-product for human consumption. Long-term toxicity testing of brown algae S. tenerrimum has been limited. The novelty of this study was to explore the long-term toxicity of the brown algae S. tenerrimum in a zebrafish model. Adult zebrafish (Danio rerio) play a crucial role in toxicity testing and are of significant importance in pharmaceutical research (22). One of the key advantages of using adult zebrafish in toxicity testing is their physiological maturity, which allows the study of the effects of substances on fully developed organisms. This is particularly important when evaluating chronic toxicity, long-term exposure effects, and the impact on adult organ systems. Adult zebrafish possess well-developed organ systems that closely resemble those of the human system, making them suitable for studying the potential toxic effects on various organs and tissues (23),(24). The primary goal of this research was to assess in-vitro toxicity in the neuroblastoma cell line SH-SY5Y and to investigate both acute and subchronic in-vivo toxicity in a zebrafish model. Additionally, the secondary aim of the study was to analyse the histopathological changes in zebrafish following a 96-hour exposure to acute toxicity.

Material and Methods

This preclinical interventional research was conducted at the Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, Tamil Nadu, India in September 2022. The study was approved by the Institutional Ethics Committee of Sri Ramachandra Institution of Higher Education and Research (Approval No. IAEC/62/SRIHER/721/2020).

Acute toxicity was carried out for 96 hours, and Subchronic toxicity was carried out for 14 days. Each group in the study contained seven fishes according to The Organisation for Economic Cooperation and Development (OECD) 203 guideline (23).

Study Procedure

Collection and verification of algae: The algae samples were collected from the Tuticorin region and verified by a former technical officer at the “Mandapam Regional Centre of Central Marine Fisheries Research Institute” located at Marine Post, Ramnad district, Tamil Nadu, India.

Preparation of methanolic extract: The seaweed S. tenerrimum was pulverised into a fine powder using a mixer grinder. The pulverised sample was extracted using a Soxhlet (Borosil) with methanol as the solvent. The porous cellulose thimble was loaded with 50 g of the powder sample after it was weighed. A total of 200 mL of methanol was poured into the round-bottom flask that was connected to an extractor and the condenser. The reservoir round-bottom flask was placed in a heating mantle and heated to 65°C for a period of 18 hours. The extraction process continued until the dark brown hue of the seaweed changed into a colourless state. The resulting solvent extract was then concentrated by passing it through a rotary evaporator at a lower temperature and in a vacuum condition. The concentrated extract was placed in a container for further investigation and cold storage under -4°C (4),(25).

Cytotoxicity study of S. tenerrimum on SH-SY5Y cell line: 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT) assay was used to assess the methanolic extract S. tenerrimum cytotoxicity in the neuroblast SH-SY5Y cell line (Mossman, 1983). The SH-SY5Y cell line is a widely used human neuroblastoma cell line. It was originally derived from a bone marrow biopsy of a neuroblastoma patient and has become a valuable tool in neurobiological and neuropharmacological research. SH-SY5Y cells are often used to study processes related to neurodevelopment, neuronal differentiation, neurotransmission, and neurodegenerative diseases, making them a valuable model for understanding various aspects of the nervous system. The cells were seeded into 96-well microplates at a density of 1×105 cells per well and incubated at 37°C for 48 hours in a 5% CO2 incubator until they reached 70- 80% confluence.

Then, the medium was changed, and the cells were treated with five different concentrations of samples (6.25, 12.5, 25, 50, and 100 μg/mL) and incubated for 24 hours. The cells were then rinsed with phosphate-buffered saline (PBS, pH 7.4), and 20 μL of an MTT solution containing 5 mg/mL of MTT in PBS was added to each well. The plates were subsequently placed in a dark environment and maintained at a temperature of 37°C for a duration of two hours. The formazan crystals were dissolved in 100 μL of Dimethyl Sulfoxide (DMSO), and the absorbance was measured using spectrophotometry at a wavelength of 570 nm (26),(27). The digital inverted microscope (40x magnification) was used to observe and photograph the morphological changes of both untreated (control) and treated cells.

Cell viability (%)=(Absorbance of sample/Absorbance of control)×100 (28).

Acute Toxicity Testing of Methanolic Extract of S. tenerrimum

Experimental animal:

Inclusion criteria: Healthy, adult zebrafish (three months) of AB strain.

Exclusion criteria: Unhealthy or injured zebrafish, fishes less than three months.

A total of 102 Adult Danio rerio (Zebrafish) of AB strain of either sex were purchased from a certified vendor. Sixty fishes were used for acute toxicity. The fishes were divided into the seven groups with different concentrations of S. tenerrimum and along with one control group.

Fifty-six fishes were selected for the acute toxicity testing. Four fishes were excluded based on the exclusion criteria. For subchronic toxicity, another 42 fishes were used.

The zebrafish with an average weight of 0.3 g were acclimated for 10 days in a glass aquarium with a capacity of 50 liters and kept in well-aerated water with a temperature of 28°C. The light-dark cycle was about 14:10 hours. The zebrafish were given commercial food twice a day, in the morning they were given flakes, and in the evening, they were fed by live artemia (24),(29). The animal ethics committee approved the study.

Acute toxicity: According to the guidelines established by the OECD 203 (https://www.oecd-ilibrary.org/environment/test-no-203-fishacute-toxicity-test_9789264069961-en), a test to determine the acute toxicity of Methanolic Extract of S. tenerrimum (MEST) was carried out on adult zebrafish for 96 hours. Seven different concentrations of MEST (12.5, 25, 50, 100, 200, 400, and 800 mg/L) along with control were used in the study (30). Seven zebrafish of either sex were exposed to each concentration in a 5L capacity rectangular tank for 96 hours.

After 24, 48, 72, and 96 hours of exposure, mortalities were reported, and the LC50 values were calculated. Fish were concluded dead when they showed no observable signs of movement and failed to react when their caudal peduncle was touched. After the dead fish were removed, the tank was carefully cleaned (31). The fish were deprived of food either prior to the commencement or during the course of the experiment.

Histopathology of zebrafish based on acute toxicity: After the 96th hour of exposure, fish were euthanised using the hypothermia method. Euthanasia in zebrafish refers to the humane and ethical practice of intentionally causing the painless and swift death of the animal for scientific research or ethical reasons (32). At the concentration of 400 mg/L, only one fish died, but at the concentration of 800 mg/L, all fishes died during the 96 hours of exposure. At the end of the experiment, a total of 48 fishes were alive and 8 fishes died for the histopathological study. The fish were placed in the cold temperature of 0-4°C for five minutes. The liver, brain, and heart were collected, and a smear with Haematoxylin and Eosin (H&E) was prepared for histopathological study (30).

Subchronic toxicity testing of methanolic extract of S. tenerrimum: Subchronic toxicity test was performed for 14 days. The concentration of the test compound used in this experiment was selected based on the LC50 value obtained from the acute toxicity test. For the subchronic study, another 42 fishes were selected. Fishes were divided into five different concentrations of algal extract and with one control. The fishes selected for the experiment were exposed to 31.25, 62.5, 125, 250, and 500 mg/L of S. tenerrimum extract for 14 days. The control group was treated with system water. Each group contained seven fish. Feeding was done once a day, and the extra food and excreted waste were eliminated one hour after feeding. The mortality of fish was tracked and recorded (33). Dead fish were removed immediately from the test tank once mortalities were reported to avoid future infection.

Statistical Analysis

The LC50 values obtained from the MTT assay and the zebrafish toxicity model were determined through linear equation analysis and graphically represented in a bar chart using MS Excel.

Results

Cellular viability was assessed through an in-vitro MTT assay, providing critical insights into cell viability. The Optical Density (OD) served as the basis for determining the percentage of viable cells within the test sample (34). (Table/Fig 1) succinctly summarises the percentages of viable cells and the extent of cell inhibition. The LC50 value of the MEST was meticulously determined via a dose-response curve analysis, yielding a precise value of 140.014 μg/mL. It is noteworthy that the negative impacts of MEST are primarily observed at higher concentrations, underlining its potential as a therapeutic agent at lower dosages.

At the concentrations of 6.25 and 12.5 μg/mL, no precipitated cell was observed, and at 25 μg/mL, precipitation of the cell was initiated. At concentrations of 50 μg/mL and 100 μg/mL, the precipitation of cells was increased and clearly visualised, indicated with the red arrow (Table/Fig 2).

In screenings of natural products to assess their pharmacological potential, one of the essential preliminary steps is the evaluation of the toxic properties associated with medicinal products, including extracts, isolated compounds, and formulations. In this critical phase of assessment, the determination of the LD50 typically takes precedence. This measurement, which signifies the lethal dose at which 50% of the test subjects succumb, serves as the foundational point of reference. Moreover, the acute toxicity study plays a pivotal role by furnishing initial insights into the mechanism of toxic action exhibited by a given substance (35). The present study findings indicate that the methanolic extract of S. tenerrimum exhibited a toxicity level resulting in a 100% fatality rate at the highest concentration of 800 mg/L (Table/Fig 3).

The LC50, or median lethal concentration, refers to the concentration of a tested compound that is estimated to cause mortality in 50% of the test organisms within the designated test duration. No mortality was detected within the concentration range of 12.5 mg/L to 200 mg/L. Fish mortality commenced at the 400 mg/L concentration, with an observed mortality rate of 14.28% after 24 hours of exposure to the algal extract (Table/Fig 3). The maximum observed fish mortality occurred at the highest concentration tested, 800 mg/L, within just 24 hours of exposure, resulting in a 100% mortality rate at 96 hours of exposure MEST (Table/Fig 3),(Table/Fig 4). Notably, as the exposure duration extended from 24 to 96 hours, there was a clear and dose-dependent increase in the mortality rate (Table/Fig 4). LC50 values at 24th, 48th, 72nd, and 96th hours is shown in (Table/Fig 5). No mortality was observed in the control group.

Subchronic toxicity: No mortality was detected within the concentration range of 31.25 mg/L to 125 mg/L. Fish mortality commenced at the 250 mg/L concentration, with an observed mortality rate of 14.28% (Table/Fig 6).

The maximum observed fish mortality occurred at the highest concentration tested, 500 mg/L, resulting in a 71.43% mortality rate at the 14th day of exposure MEST (Table/Fig 6),(Table/Fig 7). There was a clear and dose-dependent increase in the mortality rate (Table/Fig 7).

Subchronic toxicity: The LC50 values, which represent the lethal concentration at which 50% of a population is expected to perish, were determined at various time points during a toxicological study.

Specifically, these measurements were taken on the 3rd, 7th, 11th, and 14th days of the experiment. The results indicate a progressive decrease in the concentration required to cause a 50% mortality rate in the test subjects over time. On the third day of the study, the LC50 value was up to 1760.007 mg/L, signifying that a relatively large dosage of algal extract was required to induce mortality at this early stage (Table/Fig 8). As the experiment progressed and continued over time, it became increasingly evident that the toxicity levels associated with MEST started to increase. By the seventh day, the LC50 had notably decreased to 824.455 mg/L, indicating a heightened level of toxicity in comparison to the initial measurement. This pattern persisted, with the LC50 values steadily declining to 477.135 mg/L on the 11th day and eventually reaching 404.196 mg/L by the fourteenth day. These findings highlight the dynamic nature of the substance’s toxicity, with a notable increase in lethality over the course of the study period. There was no mortality observed in the control group.

(Table/Fig 9) shows histopathological changes in the liver of zebrafish exposed to different concentrations of the methanolic extract of S. tenerrimum. (Table/Fig 10) shows the histopathological analysis of zebrafish brain exposed to different concentrations of the methanolic extract of S. tenerrimum. The heart of fish at 800 mg/L showed mild disintegration of muscle fibers (myomalacia) and oedema. The heart showed normal cardiac muscle bundle with myocytes in the group from 12.5 mg/L to 400 mg/L. No lesions or other pathological conditions were observed in the control group (Table/Fig 11).

Discussion

The study investigated the cytotoxicity of S. tenerrimum, specifically its impact on the SH-SY5Y cell line. Using an in-vitro MTT assay, cellular viability was assessed, and the MEST demonstrated as a potential therapeutic agent at lower dosages, with negative impacts observed at higher concentrations. The LC50 value was determined to be 140.014 μg/mL. The acute toxicity study reveals a 100% fatality rate at the highest concentration (800 mg/L) in fish, with a dose-dependent increase in mortality over 24 to 96 hours.

LC50 values were calculated at different time points. In subchronic toxicity, LC50 values progressively decreased over days, indicating an increase in toxicity during the study period. Histopathological examination after acute toxicity in zebrafish revealed morphological changes in the liver, brain, and heart at the highest concentration, with vacuole formation, inflammatory responses, and mild disintegration observed. Overall, the study suggested a dose-dependent cytotoxic and toxic effect of S. tenerrimum, emphasising the importance of careful dosage considerations in potential therapeutic applications.

Another study done by Purnomo Y et al., discovered that the toxicity level of Urena lobata leaf extract is notably higher on zebrafish embryos compared to juvenile and adult stages. This heightened sensitivity in embryos is attributed to their underdeveloped metabolic enzymes and organ systems, which increase their susceptibility to the extract’s active constituents (36). Xavier J and Kripasana K observed the toxic effects of Enydra fluctuans, noting that the plant extract proved to be 100% lethal within a mere 24 hours of exposure, with over 70% mortality at a dose of 200 mg/L in zebrafish. Interestingly, no toxicity was observed with ethanolic extract doses of ≤50 mg/L (30).

Moreover, Chinese Momordica charantia was found to induce scoliosis in zebrafish at concentrations ranging from 125 to 1000 μg/mL, while a concentration of 1000 μg/mL led to a gradual decrease in heartbeat. Severe necrotic liver damage was evident in fish treated with Momordica charantia extracts, primarily due to the presence of momordin, a key phytocompound in the plant known for inducing toxicity in animals and fishes (37). Contrary to the preceding studies, the methanolic extract of S. tenerrimum was determined to be safe in adult zebrafish. However, additional long-term toxicological and histopathological data are required to further substantiate this finding.

Limitation(s)

Despite several advantages, some limitations emerge when attempting to study the zebrafish model, including the challenge of accurately measuring the compound intake by zebrafish. The process necessitates a skilled person to handle the zebrafish. Zebrafish are delicate creatures, and any mishandling can lead to inaccurate results or harm to the animals, making their care and experimentation a specialised task. Secondly, the dosages used in zebrafish experiments cannot be easily translated directly to rodent or human doses, and vice versa. This discrepancy arises from the significant physiological differences between these species. Zebrafish, being aquatic and considerably smaller than rodents or humans, have distinct metabolic rates, drug absorption rates, and sensitivities to certain compounds.

As a result, any findings from zebrafish studies must be carefully interpreted and cannot be directly applied to larger animals or humans without further adjustment and consideration of these interspecies variations (38). These limitations underscore the importance of conducting additional research and validations when seeking to extrapolate zebrafish study results to broader applications, particularly in the context of drug development or toxicology studies.

Conclusion

Currently, the zebrafish model has gained extensive recognition in the field of pharmacological and toxicological research owing to its diverse range of early morphology, husbandry, and size. In toxicology, the zebrafish model is used to assess human risk and screen drugs in the drug discovery process. From the results of acute and subchronic toxicity in this study, it was concluded that the methanolic extract of S. tenerrimum was found to be toxic to zebrafish in a dose-dependent manner. A clear correlation between concentration and mortality rate was observed, with an increase in concentration resulting in higher mortality rates. To ensure safety and avoid potential adverse effects, careful consideration of the extract’s concentration is crucial.

At low concentrations, the methanolic extract of S. tenerrimum was found to be safe for zebrafish. However, when zebrafish were exposed to higher concentrations of 800 mg/L, severe histopathological changes were observed, leading to damage in vital organs. This finding highlights the importance of exercising caution and using appropriate dosages to prevent harm. To enhance safety data and gain more comprehensive insights, further long-term toxicity investigation in other higher species is recommended.

Acknowledgement

Author would like to thank Department of Pharmacology and Management of SRIHER, Chennai, Tamil Nadu, India.

References

1.
Biris-Dorhoi ES, Michiu D, Pop CR, Rotar AM, Tofana M, Pop OL, et al. Macroalgae- A sustainable source of chemical compounds with biological activities. Nutrients. 2020;12(10):3085. [crossref][PubMed]
2.
Barbalace MC, Malaguti M, Giusti L, Lucacchini A, Hrelia S, Angeloni C. Anti-inflammatory activities of marine algae in neurodegenerative diseases. Int J Mol Sci. 2019;20(12):3061. [crossref][PubMed]
3.
Alves C, Silva J, Pinteus S, Gaspar H, Alpoim MC, Botana LM, et al. From marine origin to therapeutics: The antitumor potential of marine algae-derived compounds. Front Pharmacol. 2018;9:777.[crossref][PubMed]
4.
Kumar P, Senthamilselvi S, Govindaraju M. GC-MS profiling and antibacterial activity of Sargassum tenerrimum. J Pharm Res. 2013;6(1):88-92. [crossref]
5.
Azhagu Raj R, Gana Sundari G, Mala K, Prakash A. Preliminary physico-chemical properties of marine macroalga sargassum tenerrimum (J. Agardh) (Fucales, Sargassaceae). International Research Journal of Chemistry. Online & Print. 2015;11:27-43.
6.
Hakim M, Patel IIIa C. Phytochemical evaluation, FT-IR and RP-HPLC Analysis of marine brown algae collected from the coastal area of Okha in Gujarat. Egypt J Agric Res. 2023;101(1):54-60.
7.
Albratty M, Alhazmi HA, Meraya AM, Najmi A, Alam MS, Rehman Z, et al. Spectral analysis and antibacterial activity of the bioactive principles of Sargassum tenerrimum J. Agardh collected from the Red sea, Jazan, Kingdom of Saudi Arabia. Braz J Biol. 2021;83:e249536. [crossref][PubMed]
8.
Kalasariya HS, Patel NB. Phycochemical characterization of marine Macroalga Sargassum tenerrimum collected from Beyt Dwarka, Western coast of Gujarat, India. Oriental Journal of Chemistry. 2022;38(2):361. [crossref]
9.
Speisky H, Shahidi F, Costa de Camargo A, Fuentes J. Revisiting the oxidation of flavonoids: Loss, conservation or enhancement of their antioxidant properties. Antioxidants (Basel). 2022;11(1):133. [crossref][PubMed]
10.
Baharara J, Amini E, Salek-Abdollahi F. Anti-inflammatory properties of saponin fraction from Ophiocoma erinaceus. Iranian Journal of Fisheries Sciences. 2020;19(2):638-52.
11.
Elekofehinti OO, Iwaloye O, Olawale F, Ariyo EO. Saponins in cancer treatment: Current progress and future prospects. Pathophysiology. 2021;28(2):250-72. [crossref][PubMed]
12.
Qamar A, Bhatt DL. Effect of low cholesterol on steroid hormones and vitamin E levels: Just a theory or real concern? Circ Res. 2015;117(8):662-64. [crossref][PubMed]
13.
Lopez-Corona AV, Valencia-Espinosa I, González-Sánchez FA, Sánchez-López AL, Garcia-Amezquita LE, Garcia-Varela R. Antioxidant, anti-inflammatory and cytotoxic activity of phenolic compound family extracted from raspberries (Rubus idaeus): A general review. Antioxidants (Basel). 2022;11(6):1192. [crossref][PubMed]
14.
Fauzi A, Lamma S, Ruslin M. Total tannin levels analysis of brown algae (Sargassum sp. and Padina sp.) to prevent blood loss in surgery. J Dentomaxillofac Sci. 2018;3(1):37-40. [crossref]
15.
Solanki AD, Patel IIIa C. Sargassum tenerrimum-mediated green synthesis of silver nanoparticles along with antimicrobial activity. Applied Nanoscience. 2023;13(6):4415-25. [crossref]
16.
Sowmiya R, Prasanna Kumar S, Deepak P, Ramkumar R, Balasubramani G, Aiswarya D, et al. In-vitro antiplasmodial activity of native Indian seaweed Sargassum Sp. Asian J Pharm Clin Res. 2016;9(2):101-06.
17.
Patra S, Muthuraman MS, Prabhu AR, Priyadharshini RR, Parthiban S. Evaluation of antitumor and antioxidant activity of Sargassum tenerrimum against Ehrlich ascites carcinoma in mice. Asian Pac J Cancer Prev. 2015;16(3):915-21. [crossref][PubMed]
18.
Haider MS, Li Z, Lin H, Jamil K, Wang BP. In-vivo study of antiallergenicity of ethanol extracts from Sargassum tenerrimum, Sargassum cervicorne and Sargassum graminifolium turn. European Food Research and Technology. 2009;229(3):435-41. [crossref]
19.
Manoj SG, Mahesh KP, Vasanthi M, Anant A. Anticoagulant property of sulphated polysaccharides extracted from marine brown algae collected from Mandapam Island, India. Afr J Biotechnol. 2013;12(16):1937-45. [crossref]
20.
Lindsey A, Issac R, Prabha ML, Renitta RE, Catherine A, Samrot AV, et al. Evaluation of antidiabetic activity of Sargassum tenerrimum in Streptozotocin-induced diabetic mice. J Pure Appl Microbiol. 2021;15(4):2462-72. [crossref]
21.
Tao G, Dagher F, Moballegh A, Ghose R. Role of oxidative stress in the efficacy and toxicity of herbal supplements. Curr Opin Toxicol. 2020;20:36-40. [crossref]
22.
Chahardehi AM, Arsad H, Lim V. Zebrafish as a successful animal model for screening toxicity of medicinal plants. Plants (Basel). 2020;9(10):1345. [crossref][PubMed]
23.
Magyary I. Recent advances and future trends in zebrafish bioassays for aquatic ecotoxicology. Ecocycles. 2018;4(2):12-18. [crossref]
24.
Nishimura Y, Inoue A, Sasagawa S, Koiwa J, Kawaguchi K, Kawase R, et al. Using zebrafish in systems toxicology for developmental toxicity testing. Congenit Anom (Kyoto). 2016;56(1):18-27. [crossref][PubMed]
25.
Rather GA, Nanda A, Raj E, Mathivanan N, Thiruvengadam K, Sofi MA, et al. Determination of phytochemicals, in-vitro antioxidant and antibacterial activity of lavandula angustifolia mill. Res J Pharm Technol. 2023;16(3):1161-66. [crossref]
26.
Mettupalayam Kaliyannan Sundaramoorthy P, Kilavan Packiam K. In-vitro enzyme inhibitory and cytotoxic studies with Evolvulus alsinoides (Linn.) Linn. Leaf extract: A plant from Ayurveda recognized as Dasapushpam for the management of Alzheimer’s disease and diabetes mellitus. BMC Complement Med Ther. 2020;20(1):129. [crossref][PubMed]
27.
Mairuae N, Connor JR, Buranrat B, Lee SY. Oroxylum indicum (L.) extract protects human neuroblastoma SH SY5Y cells against β amyloid induced cell injury. Mol Med Rep. 2019;20(2):1933-42. [crossref][PubMed]
28.
Parikh KN, Ramasamy K, Kadal KK, Kumaravelu P. Antiproliferative and proapoptotic effects of Vitamin D3 in human neuroblastoma cell lines SH-SY5Y: An in-vitro study. J Clin Diagn Res. 2023;17(1):FC01-FC05. [crossref]
29.
Jorge S, Félix L, Costas B, Valentim AM. Housing conditions affect adult zebrafish (Danio rerio) behavior but not their physiological status. Animals (Basel). 2023;13(6):1120. [crossref][PubMed]
30.
Xavier J, Kripasana K. Acute toxicity of Leaf extracts of Enydra fluctuans Lour in Zebrafish (Danio rerio Hamilton). Scientifica (Cairo). 2020;2020:3965376. [crossref]
31.
Satpathy L, Parida SP. Acute toxicity assessment and behavioral responses induced by Kandhamal Haladi in Adult Zebrafish (Danio rerio). Biointerface Res Appl Chem. 2020;11(1):7368-81. [crossref]
32.
Ferreira JM, Félix L, Jorge S, Monteiro SM, Olsson IAS, Valentim AM. Anesthesia overdose versus rapid cooling for euthanasia of adult zebrafish. Zebrafish. 2022;19(4):148-59. [crossref][PubMed]
33.
Yakubu N, Ahmad S, Usman H, Abubakar H, Amuzat A. Acute and chronic toxicity effects of 2, 6-Bis (2, 5-Dimethoxybenzy-Lidene) Cyclohexanone (BDMC33) in Zebrafish (Danio rerio) tested on adulthood life stage. IOSR J Pharm Biol Sci. 2018;8(8):18-27.
34.
Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT assay: Utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci. 2021;22(23):12827. [crossref][PubMed]
35.
Porwal M, Khan NA, Maheshwari KK. Evaluation of acute and subacute oral toxicity induced by ethanolic extract of Marsdenia tenacissima leaves in experimental rats. Sci Pharm. 2017;85(3):29. [crossref][PubMed]
36.
Purnomo Y, Aini N, Widodo AM. Acute toxicity level of pulutan (Urena lobata) leaf extract on Zebrafish (Danio rerio) and its analysis by in silico study. Universitas Islam Malang Institutional Repository. 2018. Available from: https://repository. unisma.ac.id/handle/123456789/1928.
37.
Thiagarajan SK, Rama Krishnan K, Ei T, Husna Shafie N, Arapoc DJ, Bahari H. Evaluation of the effect of aqueous Momordica charantia Linn. extract on zebrafish embryo model through acute toxicity assay assessment. Evid Based Complement Alternat Med. 2019;2019:9152757. [crossref][PubMed]
38.
Adhish M, Manjubala I. Effectiveness of zebrafish models in understanding human diseases- A review of models. Heliyon. 2023;9(3):e14557[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2024/66816.19397

Date of Submission: Jul 31, 2023
Date of Peer Review: Sep 02, 2023
Date of Acceptance: Mar 30, 2024
Date of Publishing: May 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? No
• For any images presented appropriate consent has been obtained from the subjects. No

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Aug 01, 2023
• Manual Googling: Feb 26, 2024
• iThenticate Software: Feb 28, 2024 (8%)

ETYMOLOGY: Author Origin

EMENDATIONS: 9

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com